<DOC>
	<DOCNO>NCT00961207</DOCNO>
	<brief_summary>Study Hypothesis : Reduction albuminuria show decrease progression diabetic nephropathy . In diabetic nephropathy patient treat maximal antihypertensive dos dual RAAS blockade ( total daily dose valsartan 320 mg either enalapril 40 mg benazepril 40 mg daily , losartan 100mg ) , persistent albuminuria reflect additional RAAS activation . Microvascular renal disease due increase RAAS activation may effectively treat triple blockade addition direct renin inhibitor ( DRI ) Aliskiren .</brief_summary>
	<brief_title>Triple Blockade Renin Angiotensin Aldosterone System Diabetic ( Type 1 &amp; 2 ) Proteinuric Patients</brief_title>
	<detailed_description />
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<criteria>Macroalbuminuria &gt; 300mg/g Microalbuminuria 30300mg/g Stable max dose ACEI ARB ( Can also titrate max dosage ACEI ARB stable dos least 2 week ) Blood pressure &lt; 130/80 mm Hg time enrollment Diabetic either Type 1 2 GFR &lt; 60 m/min Potassium &gt; 5mg/dl time enrollment Pregnant History Angioedema ACEI cough Allergic ARB , ACEI , DRI A1C &gt; 9 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>